Medicare Enrolled

Dr. Estelamari Rodriguez, MD

Hematology & Oncology · Miami, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
1475 NW 12TH AVE, Miami, FL 33136
3052435302
Registered in NPPES since 2006
NPI: 1194887034 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rodriguez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rodriguez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rodriguez

Dr. Estelamari Rodriguez is a hematology & oncology specialist in Miami, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rodriguez performed 895 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Rodriguez received a total of $132,714 from 63 pharmaceutical and/or device companies across 822 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rodriguez is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ Top 45% volume in FL $132,714 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
895
Medicare services
Top 45% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
534 $79 $299
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
308 $51 $193
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
53 $106 $507
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$132,714
Total received (2018-2024)
Avg $18,959/year across 7 years
Top 8% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
822
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$30,165
2023
$15,065
2022
$17,495
2021
$16,857
2020
$806
2019
$42,585
2018
$9,742

Payments by company (2024)

AstraZeneca Pharmaceuticals LP
$8,828
Janssen Biotech, Inc.
$6,362
Lilly USA, LLC
$5,217
PFIZER INC.
$3,278
Amgen Inc.
$1,947
Daiichi Sankyo Inc.
$1,606
E.R. Squibb & Sons, L.L.C.
$1,550
Regeneron Healthcare Solutions, Inc.
$245
Gilead Sciences, Inc.
$223
AstraZeneca UK Limited
$158
Genentech USA, Inc.
$132
ARRAY BIOPHARMA INC
$108
Merck Sharp & Dohme LLC
$99
Novartis Pharmaceuticals Corporation
$83
Immunocore Limited
$66
Eisai Inc.
$44
Novocure Inc.
$40
TerSera Therapeutics LLC
$31
Janssen Scientific Affairs, LLC
$29
Myriad Genetic Laboratories, Inc.
$22
Takeda Pharmaceuticals U.S.A., Inc.
$21
Tempus AI, Inc
$20
Alexion Pharmaceuticals, Inc.
$20
Mirati Therapeutics, Inc.
$19
Pharmacosmos Therapeutics Inc.
$18
Top 3 companies account for 67.7% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$37,472
AstraZeneca Pharmaceuticals LP
$27,379
Boehringer Ingelheim Pharmaceuticals, Inc.
$10,441
Lilly USA, LLC
$7,449
Janssen Biotech, Inc.
$6,876
Regeneron Pharmaceuticals, Inc.
$5,743
E.R. Squibb & Sons, L.L.C.
$5,355
PFIZER INC.
$5,293
Regeneron Healthcare Solutions, Inc.
$4,518
Novartis Pharmaceuticals Corporation
$2,936
Daiichi Sankyo Inc.
$2,633
Amgen Inc.
$2,424
EISAI INC.
$2,313
AstraZeneca UK Limited
$1,823
G1 Therapeutics, Inc.
$1,604
Genentech, Inc.
$1,535
Janssen Scientific Affairs, LLC
$1,061
Novocure Inc.
$1,005
Merck Sharp & Dohme Corporation
$607
EMD Serono, Inc.
$545
Celgene Corporation
$391
Merck Sharp & Dohme LLC
$295
TESARO, Inc.
$239
Gilead Sciences, Inc.
$235
Takeda Pharmaceuticals U.S.A., Inc.
$208
Incyte Corporation
$179
Bayer HealthCare Pharmaceuticals Inc.
$173
Astellas Pharma US Inc
$172
ARRAY BIOPHARMA INC
$150
Eisai Inc.
$149
Janssen Pharmaceuticals, Inc
$127
MEDIVATION FIELD SOLUTIONS LLC
$121
Ipsen Biopharmaceuticals, Inc
$113
Pharmacyclics LLC, An AbbVie Company
$94
Coherus Biosciences Inc.
$85
AbbVie, Inc.
$77
Clovis Oncology, Inc.
$73
Immunocore Limited
$66
Exelixis Inc.
$54
Seattle Genetics, Inc.
$51
Rigel Pharmaceuticals, Inc.
$49
Helsinn Therapeutics (U.S.), Inc.
$47
Taiho Oncology, Inc.
$46
Dova Pharmaceuticals
$43
GlaxoSmithKline, LLC.
$42
Teva Pharmaceuticals USA, Inc.
$40
Array BioPharma Inc.
$37
GENZYME CORPORATION
$34
TerSera Therapeutics LLC
$31
Foundation Medicine, Inc.
$29
Agios Pharmaceuticals, Inc.
$27
Mylan Institutional Inc.
$24
Myriad Genetic Laboratories, Inc.
$22
Tempus AI, Inc
$20
Catalyst Pharmaceuticals, Inc.
$20
Alexion Pharmaceuticals, Inc.
$20
Mirati Therapeutics, Inc.
$19
Genmab U.S., Inc.
$18
Pharmacosmos Therapeutics Inc.
$18
Kyowa Kirin, Inc.
$18
Verastem, Inc.
$18
EUSA Pharma (US) LLC
$15
AMAG Pharmaceuticals, Inc.
$14
Top 3 companies account for 56.7% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · BENDEKA · BOSULIF · BRAFTOVI · Balversa · Bavencio · Braftovi · CALQUENCE · CARVYKTI · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · Doptelet · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · ERLEADA · Enhertu · Epkinly · Erleada · FASLODEX · FERAHEME · FIRDAPSE · Fabhalta · Fulphila · GAZYVA · GILOTRIF · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · Lupron · MEKINIST · MONOFERRIC · MVASI · MYLOTARG · MYRISK · Neulasta · OPDIVO · Optune Lua (NovoTTF-200T) · PADCEV · PIQRAY · POTELIGEO · PROMACTA · Perjeta · RETEVMO · ROZLYTREK · RYBREVANT · RYDAPT · Revlimid · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SOMATULINE DEPOT · SPRYCEL · SUTENT · Sylvant · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · Tarceva · Tavalisse · Tecentriq · Trodelvy · ULTOMIRIS · Udenyca · VELCADE · VENCLEXTA · VERZENIO · VOTRIENT · Vectibix · Venclexta · XALKORI · XARELTO · XOSPATA · XT CDX · XTANDI · Xofigo · ZEJULA · ZYTIGA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Miami?
Compare hematology & oncology specialists in the Miami area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
179
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
JACKSON HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rodriguez is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rodriguez experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rodriguez performed 534 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Rodriguez receive payments from pharmaceutical companies?
Yes. Dr. Rodriguez received a total of $132,714 from 63 companies across 822 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rodriguez's costs compare to other hematology & oncology specialists in Miami?
Dr. Rodriguez's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rodriguez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →